Avoid common mistakes on your manuscript.
Correction to: Journal of Cancer Research and Clinical Oncology https://doi.org/10.1007/s00432-022-04418-y
In Fig. 5 of this article, there were two errors in Fig. 5c, right panel. Firstly, the title of the graph (in the right panel) that had read “Target tumour” should have read “Off-target tumour”. In addition, the graph had presented the raw tumour volume data, and it should have presented the % tumour volume increase data. Asterisks that depict the level of significance had also been missing;
The Fig. 5c should have appeared as shown below:
Sonodynamic treatment of T110299 tumours. A % cell viability of T110299 cells treated in the absence (no HPNP) and the presence of nanoparticles (HPNP), without (no US) and with ultrasound exposure at 3 W/cm2 and 50% DC, for 30 s, at normoxic and hypoxic conditions. B In vivo treatment protocol. C Plot of % change of target and off-target tumour volumes treated with no treatment (untreated), ultrasound only (US), nanoparticles carrying hematoporphyrin (HPNP) and nanoparticles carrying hematoporphyrin with ultrasound, i.e. sonodynamic therapy, SDT, (HPNPs + US). D Plot of % change of target and off-target tumour volumes trated with SDT. E The corresponding animal body weight increase. Statistical significance was computed using Two-way ANOVA with Bonferroni post-test (A) and One-way ANOVA with Tukey multiple comparison test (C) (*p < 0.05, **p < 0.01, ***p < 0.001). For A: the asterisks show the significance of difference between samples incubated in the presence and the absence of nanoparticles, under ultrasound exposure. Error bars represent ± the SD, where n = 5
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hadi, M.M., Farrell, S., Nesbitt, H. et al. Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol 149, 8165–8166 (2023). https://doi.org/10.1007/s00432-023-04648-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-04648-8